A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CM / cerebral malaria

[Related PubMed/MEDLINE]
Total Number of Papers: 563
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CM  (>> Co-occurring Abbreviation)
Long Form:   cerebral malaria
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Delayed iron improves iron status without altering malaria risk in severe malarial anemia. CC, SMA, ZPP
2020 Desperately Seeking Therapies for Cerebral Malaria. ---
2020 Estimating hospital catchments from in-patient admission records: a spatial statistical approach applied to malaria. EAs, SMA
2020 Expression of CD300lf by microglia contributes to resistance to cerebral malaria by impeding the neuroinflammation. ---
2020 Molecular targets in cerebral malaria for developing novel therapeutic strategies. BBB
2020 Oxidative and nitrosative stresses in cerebral malaria: can we target them to avoid a bad prognosis? ---
2020 Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation. BBB, DCs, ECM, PbA
2019 A clinical trial of enteral Levetiracetam for acute seizures in pediatric cerebral malaria. eLVT, PK, RCT, SCr
2019 Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes. ADRB, ELISA, Ig, ME, MM, MSPs
10  2019 CD14+ monocytes are the main leucocytic sources of CXCL10 in response to Plasmodium falciparum. IP-10, PBMCs
11  2019 Cerebral malaria is associated with differential cytoadherence to brain endothelial cells. EPCR, IE, UM
12  2019 Cerebral malaria. ---
13  2019 Citrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak. eCM, NO, p.i
14  2019 Elevated cerebrospinal fluid tau protein concentrations on admission are associated with long-term neurologic and cognitive impairment in Ugandan children with cerebral malaria. CSF
15  2019 Erg mediates downregulation of claudin-5 in the brain endothelium of a murine experimental model of cerebral malaria. ECM
16  2019 Experimental Cerebral Malaria Alters Blood Lipid Levels During Pathogenesis. ECM
17  2019 Experimental cerebral malaria is associated with profound loss of both glycan and protein components of the endothelial glycocalyx. ---
18  2019 gammadelta-T cells promote IFN-gamma-dependent Plasmodium pathogenesis upon liver-stage infection. ECM
19  2019 Glycocalyx breakdown is increased in African children with cerebral and uncomplicated falciparum malaria. DMMB, GAGs, GCX, MS, UM
20  2019 HIV infection compounds the lymphopenia associated with cerebral malaria in Malawian children. SMA
21  2019 In vivo noninvasive visualization of retinal perfusion dysfunction in murine cerebral malaria by camera-phone laser speckle imaging. BFS, ECM
22  2019 Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8+ T Cell Responses. ECM, PbA
23  2019 Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption. HBMEC, IE, TNF-alpha
24  2019 KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria. ---
25  2019 Kinins Released by Erythrocytic Stages of Plasmodium falciparum Enhance Adhesion of Infected Erythrocytes to Endothelial Cells and Increase Blood Brain Barrier Permeability via Activation of Bradykinin Receptors. B1R, B2R, BBB, CNS, KKS
26  2019 Modulation of anti-malaria immunity by vitamin A in C57BL/6J mice infected with heterogenic plasmodium. DCs, P.y17XL, PbANKA, VA, VAS
27  2019 MRI of Iron Oxide Nanoparticles and Myeloperoxidase Activity Links Inflammation to Brain Edema in Experimental Cerebral Malaria. CLIO-NP, MPO, RMCBS
28  2019 Neurodevelopmental Impairments 1 Year After Cerebral Malaria. ---
29  2019 Potential role of arteether on N-methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survival. NMDA, NMDARs
30  2019 Retinopathy-Positive Cerebral Malaria Is Associated With Greater Inflammation, Blood-Brain Barrier Breakdown, and Neuronal Damage Than Retinopathy-Negative Cerebral Malaria. CSF, RN, RP
31  2019 Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa. SAE
32  2019 T-lymphocytes response persists following Plasmodium berghei strain Anka infection resolution and may contribute to later experimental cerebral malaria outcomes. ---
33  2019 Targeting the Hexosamine Biosynthetic Pathway Prevents Plasmodium Developmental Cycle and Disease Pathology in Vertebrate Host. DON
34  2019 The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence. CNF1
35  2019 The Ins and Outs of Cerebral Malaria Pathogenesis: Immunopathology, Extracellular Vesicles, Immunometabolism, and Trained Immunity. EVs
36  2019 The malaria toxin hemozoin induces apoptosis in human neurons and astrocytes: Potential role in the pathogenesis of cerebral malaria. HMZ
37  2019 Whole-Blood Transcriptional Signatures Composed of Erythropoietic and NRF2-Regulated Genes Differ Between Cerebral Malaria and Severe Malarial Anemia. Nrf2, SMA
38  2018 1.5 Tesla Magnetic Resonance Imaging to Investigate Potential Etiologies of Brain Swelling in Pediatric Cerebral Malaria. DWI, MRI, SWI
39  2018 Admission EEG findings in diverse paediatric cerebral malaria populations predict outcomes. EEG
40  2018 Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. ARM, EE, HSH, NLCs, PS, ZP
41  2018 AMP-activated protein kinase (AMPK) is decreased in the mouse brain during experimental cerebral malaria. AMPK, AMPK
42  2018 Automated Detection of Malarial Retinopathy in Retinal Fundus Images obtained in Clinical Settings. MR
43  2018 Brain Endothelium: The "Innate Immunity Response Hypothesis" in Cerebral Malaria Pathogenesis. BBB, BVE, iRBCs, PRR
44  2018 Brain swelling is independent of peripheral plasma cytokine levels in Malawian children with cerebral malaria. ---
45  2018 Case Report: A Case of Severe Cerebral Malaria Managed with Therapeutic Hypothermia and Other Modalities for Brain Edema. ---
46  2018 Cerebral Malaria Causes Enduring Behavioral and Molecular Changes in Mice Brain Without Causing Gross Histopathological Damage. ---
47  2018 Cerebral Malaria in Mouse and Man. ---
48  2018 Cerebrospinal fluid Plasmodium falciparum histidine-rich protein-2 in pediatric cerebral malaria. CSF, PfHRP2
49  2018 Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure. UM
50  2018 CXCL10 stabilizes T cell-brain endothelial cell adhesion leading to the induction of cerebral malaria. ECM
51  2018 Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria. miRNA, MV, NCM
52  2018 Differentially expressed microRNAs in experimental cerebral malaria and their involvement in endocytosis, adherens junctions, FoxO and TGF-beta signalling pathways. miRNA, NCM, NI
53  2018 Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators. BBB, CNS, Dox, ECM, MMP2, PbA, TNF, WT
54  2018 Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria. IL-10, TNF
55  2018 Experimental severe malaria is resolved by targeting newly-identified monocyte subsets using immune-modifying particles combined with artesunate. ECM, IMP
56  2018 Experimental severe malaria is resolved by targeting newly-identified monocyte subsets using immune-modifying particles combined with artesunate. ECM, IMP
57  2018 Funduscopy in Cerebral Malaria Diagnosis: An International Survey of Practice Patterns. ---
58  2018 Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei. ECM
59  2018 Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria. HBO, HIF-1alpha
60  2018 MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice. BBB, DON, ECM
61  2018 Natural and Vaccine-Induced Acquisition of Cross-Reactive IgG-Inhibiting ICAM-1-Specific Binding of a Plasmodium falciparum PfEMP1 Subtype Associated Specifically with Cerebral Malaria. ELISA, EPCR, ICAM-1, IEs
62  2018 Oral administration of vitamin D and importance in prevention of cerebral malaria. PbA
63  2018 PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8+ T Cell Responses. BBB, ECM, PD-1, Pf
64  2018 Plasma and Cerebrospinal Fluid Beta-Endorphin Levels Show a Strong Association in Children with Cerebral Malaria. CSF, ELISA, mL, OAUTHC
65  2018 Proteomic profiling of the brain of mice with experimental cerebral malaria. ECM
66  2018 Proteomic profiling of the plasma of Gambian children with cerebral malaria. ---
67  2018 Rocaglates as dual-targeting agents for experimental cerebral malaria. ART, eIF4A, PfeIF4A
68  2018 Sex-Associated Differential mRNA Expression of Cytokines and Its Regulation by Sex Steroids in Different Brain Regions in a Plasmodium berghei ANKA Model of Cerebral Malaria. ---
69  2018 Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria. ECM
70  2018 Type I Interferon Receptor Variants in Gene Regulatory Regions are Associated with Susceptibility to Cerebral Malaria in Malawi. IFN
71  2018 Unravelling the roles of innate lymphoid cells in cerebral malaria pathogenesis. CNS, ECM, HCM, ILCs
72  2018 [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury]. ECM
73  2017 A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria. ---
74  2017 A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria. MRI, NMDA, PbA
75  2017 A single rapamycin dose protects against late-stage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration. ECM
76  2017 Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria. AST, ECM, PbA, rhEPO
77  2017 Automated Detection of Malarial Retinopathy in Digital Fundus Images for Improved Diagnosis in Malawian Children with Clinically Defined Cerebral Malaria. MR
78  2017 Cerebral malaria induces electrophysiological and neurochemical impairment in mice retinal tissue: possible effect on glutathione and glutamatergic system. ---
79  2017 Cerebrospinal fluid and plasma beta-endorphin levels in children with cerebral malaria. CSF
80  2017 Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria. CSF, KYNA
81  2017 Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children. ABM, AUC, CSF, FC, FDR, ROC
82  2017 Cognitive Outcomes and Psychiatric Symptoms of Retinopathy-Positive Cerebral Malaria: Cohort Description and Baseline Results. COPS, MRI
83  2017 Controlled release of artemisone for the treatment of experimental cerebral malaria. DHA
84  2017 Cytokine Profiles in Malawian Children Presenting with Uncomplicated Malaria, Severe Malarial Anemia, and Cerebral Malaria. IFN-gamma, IL-5, SMA, TNF-alpha, UCM
85  2017 Differential modulation of glial cell mediated neuroinflammation in Plasmodium berghei ANKA infection by TGF beta and IL 6. IL-6, PbA, TGF-beta
86  2017 Dysregulation of LIMK-1/cofilin-1 pathway: A possible basis for alteration of neuronal morphology in experimental cerebral malaria. ---
87  2017 Elevated cerebrospinal fluid tumour necrosis factor is associated with acute and long-term neurocognitive impairment in cerebral malaria. CNS, CSF, TNF-alpha
88  2017 Evidence from a natural experiment that malaria parasitemia is pathogenic in retinopathy-negative cerebral malaria. ---
89  2017 Exploring neurodevelopmental outcome measures used in children with cerebral malaria: the perspectives of caregivers and health workers in Malawi. CGs, ICF
90  2017 Extensive alterations of blood metabolites in pediatric cerebral malaria. ---
91  2017 High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria. CC, CI, IRR, SMA
92  2017 IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria. BBB, ECM, PbA
93  2017 Linking EPCR-Binding PfEMP1 to Brain Swelling in Pediatric Cerebral Malaria. EPCR
94  2017 Magnetic Resonance Imaging of Cerebral Malaria Patients Reveals Distinct Pathogenetic Processes in Different Parts of the Brain. ADC, DWI, MRI, PRES
95  2017 Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection. ECM
96  2017 miR-155 Modifies Inflammation, Endothelial Activation and Blood-Brain Barrier Dysfunction in Cerebral Malaria. BBB, ECM
97  2017 Plasmodium falciparum EPCR-binding PfEMP1 expression increases with malaria disease severity and is elevated in retinopathy negative cerebral malaria. EPCR, PfEMP1, RP, SM
98  2017 Plasmodium falciparum Histidine-Rich Protein-2 Plasma Concentrations Are Higher in Retinopathy-Negative Cerebral Malaria Than in Severe Malarial Anemia. AP, PfHRP2, RN, RP, SMA
99  2017 Repurposing Pharmaceuticals as Neuroprotective Agents for Cerebral Malaria. NVU
100  2017 Rupture and Release: A Role for Soluble Erythrocyte Content in the Pathology of Cerebral Malaria. ---